Additionally, FOXA1 was significantly down-regulated in CRC tumors (Figure 1F) and knockdown of FOXA1 in LS180 and SW1222 significantly decreased FORCP levels (Figure 1G and Figure 1—figure supplement 3C–E and Figure 1—figure supplement 3—source data 1). This evidence concerns the gene TMEM238L and colorectal carcinoma.